Professor of Medicine (Clinical Pharmacology)
Johns Hopkins Univ School of Medicine and Chairman, American Board of Clinical Pharmacology
Dr. Hendrix is a Professor of Medicine and Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine. He has 28 years of experience in the design and conduct of translational clinical pharmacology studies, mostly of antiretroviral drugs for HIV treatment and prevention. He is the Wellcome Professor and Director, Division of Clinical Pharmacology and Director of the Drug Development Unit in the Division. His research focuses on development of antiretroviral drugs to prevent HIV infection. His HIV prevention research has been supported by CDC, NIH, USAID, the Bill and Melinda Gates Foundation, amfAR, and sponsors in the pharmaceutical industry.
Sunday, September 10, 2023
10:00 AM - 11:30 AM PT
Disclosure(s): No financial relationships to disclose
2 - Clinical Pharmacology Innovations: Novel Methods to Inform Early Drug Development
Sunday, September 10, 2023
10:00 AM - 11:30 AM PT
Disclosure(s): No financial relationships to disclose
Tuesday, September 12, 2023
10:00 AM - 11:00 AM PT
Disclosure(s): No financial relationships to disclose
2 - How Does a Clinical Pharmacology Training Program Earn Accreditation?
Tuesday, September 12, 2023
10:00 AM - 11:00 AM PT
Disclosure(s): No financial relationships to disclose
4 - What is the New Collaboration With ACCP All About?
Tuesday, September 12, 2023
10:00 AM - 11:00 AM PT
Disclosure(s): No financial relationships to disclose